Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Low-income patients are more likely to face health insurance claims denials

Medical Economics (7/15, Shryock ) reports, “Low-income patients are more likely to have their health insurance claims denied and less likely to successfully challenge those denials than higher-income individuals, according to a study.” Investigators “found that patients from households earning less than $50,000 a year — as well as the health care providers who serve them — are significantly less likely to contest denied claims than those with higher incomes.” Moreover, “when they do challenge these denials, they are less successful in reversing them.” The findings were published in Health Affairs.

Related Links:

— “Low-income patients face uphill battle when fighting health insurance denials, Umass research finds,”Todd Shryock, Medical Economics, July 15, 2025

ED visits for cannabis hyperemesis syndrome among adolescents increased more than 10-fold

MedPage Today (7/14, Henderson) reports a study found that U.S. “emergency department (ED) visits for cannabis hyperemesis syndrome (CHS) among adolescents increased more than 10-fold in recent years, with increases observed regardless of states’ recreational cannabis legalization (RCL) status.” Researchers said that “from 2016 through 2023, CHS encounters among 13- to 21-year-olds increased by 49% per year, from 160.4 per million ED visits in 2016 to 1,968.3 per million in 2023.” Further, “CHS encounters increased by 32.5% per million ED encounters per year in states with RCL and by 49.3% per million per year in states without RCL.” They noted the “overall rate per million ED encounters for CHS was 1,909.5 in states with RCL and 834 in states without RCL.” The study was discussed in a research letter in JAMA Network Open.

Related Links:

MedPage Today (requires login and subscription)

Adding Anxiety As Qualifier For Medical Cannabis In Pennsylvania Increased Number Of Certifications, Study Suggests

HealthDay (7/11, Gotkine) reported a study suggests that “adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications.” The researchers “examined whether Pennsylvania adding anxiety disorders as a qualifying condition to obtain medical cannabis in July 2019 was associated with changes in the distribution of qualifying conditions and the total number of certifications.” They observed “there was a rapid increase in the number of certifications issued per month, from about 11,000 certifications in June 2019 to 30,000 in December 2023, which were mostly related to increases in certifications for anxiety.” Researchers noted that “after the addition of anxiety, 60.26 percent of certifications were for anxiety, while 41.47 and 10.97 percent of certifications were for chronic pain and PTSD, respectively.” The study was discussed in research letter published in the Annals of Internal Medicine.

Related Links:

— “Adding Anxiety as Qualifier for Medical Cannabis Increases Number of Certifications,”Elana Gotkine
, Elana Gotkine/i>, July 11, 2025

Nicotine Poisonings In Babies And Toddlers Have Increased In Recent Years, Study Finds

NBC News (7/14, Edwards ) reports, “The number of young children sickened after getting their…hands on nicotine products like pouches and vape e-liquids has skyrocketed in recent years.” A study found that “from 2010 through 2023, U.S. poison centers reported 134,663 cases of nicotine poisonings among kids under age 6.” The findings were published in Pediatrics.

Related Links:

— “Nicotine poisonings soar in babies and toddlers,”Erika Edwards, NBC News, July 14, 2025

Taking Metformin May Help Adolescents With Overweight Or Obesity Who Take Antipsychotic Medications Avoid Weight Gain, Research Finds

Psychiatric News (7/15) reports that “taking metformin may help” adolescents with overweight or obesity “who take antipsychotic medications avoid the weight gain commonly associated with the drugs, according to researchers.” The investigators said, “Based on our assessment…of the risks and benefits of adding [metformin] to a brief healthy lifestyle intervention among youth with [bipolar disorder] who have overweight or obesity, clinicians should strongly consider prescribing [metformin] in conjunction with [second-generation antipsychotics].” The findings (PDF) were published by the Patient-Centered Outcomes Research Institute.

Related Links:

— “Metformin May Curb Weight Gain in Youth Who Take Antipsychotics,Psychiatric News, July 15, 2025

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.